Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy

Medical device specialist Medtronic (NYSE: MDT) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow

Members of Congress Are Buying These 4 Warren Buffett Stocks. Should You?
Members of Congress Are Buying These 4 Warren Buffett Stocks. Should You?

Bipartisan support for banning U.S. senators and representatives from buying and selling stocks while they're in office is picking up momentum. President Trump recently stated that he would

EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest

The Smartest Dividend Stocks to Buy With $2,000 Right Now
The Smartest Dividend Stocks to Buy With $2,000 Right Now

Buying dividend stocks is always a smart plan. They have historically outperformed non-dividend payers by more than two-to-one (9.2% annualized return compared to 4.3% over the last 50 years,

EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U


DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program exclusively for college athletes

EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter
EQS-News: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System


DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with

This S&P 500 Stock Soared While the Market Plunged. Is It Still a Buy Now?
This S&P 500 Stock Soared While the Market Plunged. Is It Still a Buy Now?

Roughly four out of five S&P 500 (SNPINDEX: ^GSPC) stocks are in negative territory in 2025. Most of those stocks weren't immune to the meltdown that occurred in recent days following President

Humana’s Initiatives Deliver Improved Health Outcomes in Communities
Humana’s Initiatives Deliver Improved Health Outcomes in Communities


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2024 Impact Report, showcasing the company’s dedication to improving health outcomes and

Dr. Oz Is Confirmed to Lead Medicare and Medicaid. Here's What He's Said About the Programs So Far.
Dr. Oz Is Confirmed to Lead Medicare and Medicaid. Here's What He's Said About the Programs So Far.

Congress recently confirmed President Donald Trump's pick, Dr. Mehmet Oz, to lead the Centers for Medicare and Medicaid Services (CMS). Medicare and Medicaid provide healthcare insurance to an

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks

Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. He ran his hedge fund firm, Duquesne Capital Management, for 30 years, posting eye-popping average

Why Applovin Plunged in March
Why Applovin Plunged in March

Shares of digital advertising up-and-comer Applovin (NASDAQ: APP) plunged 18.2% in March, according to data from S&P Global Market Intelligence.

Applovin already had a rough February, when it was

EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB : https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB
EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement  of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution